Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anti-Peptic Ulcer Drugs Market 2018, Forecast to 2023

Publisher Name :
Date: 11-Jun-2018
No. of pages: 132

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

Scope of the Report:

This report focuses on the Anti-Peptic Ulcer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

China's anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry shocked. The Chinese government has had no qualms about openly stating that it prefers hospitals to purchase from domestic producers. That said, China's homegrown manufacturers of medical devices and medicine still lack the sophistication to produce many of the more advanced health care products the country needs. Amid rising living standards and an aging population, China's healthcare needs are set to rise sharply in the coming years.

In April 2015, China amended its Drug Administration Law, introducing two major changes.

The first is a simplification of the company set-up procedure for pharmaceutical companies. Prior to the amendment, investors that wanted to manufacture or distribute pharmaceuticals needed to have a Drug Manufacturing License or a Drug Distribution License before applying for a business license. Now, investors may apply for these after the company has been set up, significantly speeding up the incorporation process.

More importantly, the amendment removes the price controls that the Chinese government had in place for medicines. As of the year 2000, medicines that were listed on the government's Medical Insurance Catalog, and those medicines on which there was a monopoly, had their prices fixed or guided by the government. About 23 percent of the medicines on the Chinese market had government fixed or guided prices. The price of other medicines was left to market forces. While these price restrictions are now fully removed, companies still need to abide by China's anti-trust laws. Companies abusing their dominant market position are still punishable under Chinese law.

While recent moves have made it easier for foreign investors to introduce new medical products to the Chinese market, the Chinese government has at the same time placed restraints on advertising healthcare products. The final text of the revised Advertising Law was released by the National People's Congress, China main legislative body, in late April 2015. The law comes into force in September 2015.

The 2015 Advertising Law has special stipulations about advertising for medicine and medical devices. For one, advertising for anesthetics, psychotropic drugs, toxic and radioactive drugs for medical use is not allowed, nor is advertisement for drugs, treatment plans and medical devices to combat drug addiction. Advertising for prescription drugs other than those mentioned previously is only allowed in professional medical journals.

The content for medical advertisements is regulated as well. Any advertisement for drugs, medical treatment or medical devices may not contain the following:

The worldwide market for Anti-Peptic Ulcer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- AstraZeneca

- Ask-pharm

- Takeda

- Yangtze River Pharm

- Shandong Luoxin

- Huadong Medicine

- Changzhou Siyao

- Beijing Yuekang

- Guangdong Dahua

- Xian Janssen

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Proton Pump Inhibitors (PPIs)

- Potassium-Competitive Acid Blockers (P-CAB)

- Antacids

- H2 Antagonists

- Ulcer Protective Drugs

Market Segment by Applications, can be divided into

- Gastritis

- Gastric Ulcers

- Duodenal Ulcers

- Gastroesophageal Reflux Disease (GERD)

There are 15 Chapters to deeply display the global Anti-Peptic Ulcer Drugs market.

Chapter 1, to describe Anti-Peptic Ulcer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anti-Peptic Ulcer Drugs, with sales, revenue, and price of Anti-Peptic Ulcer Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Peptic Ulcer Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anti-Peptic Ulcer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anti-Peptic Ulcer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anti-Peptic Ulcer Drugs Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Anti-Peptic Ulcer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Proton Pump Inhibitors (PPIs)
1.2.2 Potassium-Competitive Acid Blockers (P-CAB)
1.2.3 Antacids
1.2.4 H2 Antagonists
1.2.5 Ulcer Protective Drugs
1.3 Market Analysis by Applications
1.3.1 Gastritis
1.3.2 Gastric Ulcers
1.3.3 Duodenal Ulcers
1.3.4 Gastroesophageal Reflux Disease (GERD)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.1.1 AstraZeneca Description
2.1.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.1.2 AstraZeneca Anti-Peptic Ulcer Drugs Product Introduction
2.1.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Anti-Peptic Ulcer Drugs Product Information
2.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global AstraZeneca Anti-Peptic Ulcer Drugs Market Share in 2017
2.2 Ask-pharm
2.2.1 Business Overview
2.2.1.1 Ask-pharm Description
2.2.1.2 Ask-pharm Headquarter, Main Business and Finance Overview
2.2.2 Ask-pharm Anti-Peptic Ulcer Drugs Product Introduction
2.2.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Anti-Peptic Ulcer Drugs Product Information
2.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Ask-pharm Anti-Peptic Ulcer Drugs Market Share in 2017
2.3 Takeda
2.3.1 Business Overview
2.3.1.1 Takeda Description
2.3.1.2 Takeda Headquarter, Main Business and Finance Overview
2.3.2 Takeda Anti-Peptic Ulcer Drugs Product Introduction
2.3.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Anti-Peptic Ulcer Drugs Product Information
2.3.3 Takeda Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Takeda Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Takeda Anti-Peptic Ulcer Drugs Market Share in 2017
2.4 Yangtze River Pharm
2.4.1 Business Overview
2.4.1.1 Yangtze River Pharm Description
2.4.1.2 Yangtze River Pharm Headquarter, Main Business and Finance Overview
2.4.2 Yangtze River Pharm Anti-Peptic Ulcer Drugs Product Introduction
2.4.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Anti-Peptic Ulcer Drugs Product Information
2.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Yangtze River Pharm Anti-Peptic Ulcer Drugs Market Share in 2017
2.5 Shandong Luoxin
2.5.1 Business Overview
2.5.1.1 Shandong Luoxin Description
2.5.1.2 Shandong Luoxin Headquarter, Main Business and Finance Overview
2.5.2 Shandong Luoxin Anti-Peptic Ulcer Drugs Product Introduction
2.5.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Anti-Peptic Ulcer Drugs Product Information
2.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Shandong Luoxin Anti-Peptic Ulcer Drugs Market Share in 2017
2.6 Huadong Medicine
2.6.1 Business Overview
2.6.1.1 Huadong Medicine Description
2.6.1.2 Huadong Medicine Headquarter, Main Business and Finance Overview
2.6.2 Huadong Medicine Anti-Peptic Ulcer Drugs Product Introduction
2.6.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Anti-Peptic Ulcer Drugs Product Information
2.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Huadong Medicine Anti-Peptic Ulcer Drugs Market Share in 2017
2.7 Changzhou Siyao
2.7.1 Business Overview
2.7.1.1 Changzhou Siyao Description
2.7.1.2 Changzhou Siyao Headquarter, Main Business and Finance Overview
2.7.2 Changzhou Siyao Anti-Peptic Ulcer Drugs Product Introduction
2.7.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Anti-Peptic Ulcer Drugs Product Information
2.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Changzhou Siyao Anti-Peptic Ulcer Drugs Market Share in 2017
2.8 Beijing Yuekang
2.8.1 Business Overview
2.8.1.1 Beijing Yuekang Description
2.8.1.2 Beijing Yuekang Headquarter, Main Business and Finance Overview
2.8.2 Beijing Yuekang Anti-Peptic Ulcer Drugs Product Introduction
2.8.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Anti-Peptic Ulcer Drugs Product Information
2.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Beijing Yuekang Anti-Peptic Ulcer Drugs Market Share in 2017
2.9 Guangdong Dahua
2.9.1 Business Overview
2.9.1.1 Guangdong Dahua Description
2.9.1.2 Guangdong Dahua Headquarter, Main Business and Finance Overview
2.9.2 Guangdong Dahua Anti-Peptic Ulcer Drugs Product Introduction
2.9.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Anti-Peptic Ulcer Drugs Product Information
2.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Guangdong Dahua Anti-Peptic Ulcer Drugs Market Share in 2017
2.10 Xian Janssen
2.10.1 Business Overview
2.10.1.1 Xian Janssen Description
2.10.1.2 Xian Janssen Headquarter, Main Business and Finance Overview
2.10.2 Xian Janssen Anti-Peptic Ulcer Drugs Product Introduction
2.10.2.1 Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Anti-Peptic Ulcer Drugs Product Information
2.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Xian Janssen Anti-Peptic Ulcer Drugs Market Share in 2017
3 Global Anti-Peptic Ulcer Drugs Market Competition, by Manufacturer
3.1 Global Anti-Peptic Ulcer Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Peptic Ulcer Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Anti-Peptic Ulcer Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Peptic Ulcer Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Anti-Peptic Ulcer Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Anti-Peptic Ulcer Drugs Market Analysis by Regions
4.1 Global Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Peptic Ulcer Drugs Sales by Regions (2013-2018)
4.1.2 Global Anti-Peptic Ulcer Drugs Revenue by Regions (2013-2018)
4.2 North America Anti-Peptic Ulcer Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Anti-Peptic Ulcer Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Peptic Ulcer Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Anti-Peptic Ulcer Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Peptic Ulcer Drugs Sales, Revenue and Growth Rate (2013-2018)
5 North America Anti-Peptic Ulcer Drugs by Countries, Type, Application and Manufacturers
5.1 North America Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Peptic Ulcer Drugs Sales by Countries (2013-2018)
5.1.2 North America Anti-Peptic Ulcer Drugs Revenue by Countries (2013-2018)
5.1.3 United States Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
5.2 North America Anti-Peptic Ulcer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Anti-Peptic Ulcer Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Anti-Peptic Ulcer Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Anti-Peptic Ulcer Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Anti-Peptic Ulcer Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Application (2013-2018)
6 Europe Anti-Peptic Ulcer Drugs by Countries, Type, Application and Manufacturers
6.1 Europe Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Peptic Ulcer Drugs Sales by Countries (2013-2018)
6.1.2 Europe Anti-Peptic Ulcer Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Anti-Peptic Ulcer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Anti-Peptic Ulcer Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Anti-Peptic Ulcer Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Anti-Peptic Ulcer Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Anti-Peptic Ulcer Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Anti-Peptic Ulcer Drugs by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Peptic Ulcer Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Countries (2013-2018)
7.1.3 China Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Anti-Peptic Ulcer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Anti-Peptic Ulcer Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Anti-Peptic Ulcer Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Anti-Peptic Ulcer Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Application (2013-2018)
8 South America Anti-Peptic Ulcer Drugs by Countries, Type, Application and Manufacturers
8.1 South America Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Peptic Ulcer Drugs Sales by Countries (2013-2018)
8.1.2 South America Anti-Peptic Ulcer Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
8.2 South America Anti-Peptic Ulcer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Anti-Peptic Ulcer Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Anti-Peptic Ulcer Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Anti-Peptic Ulcer Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Anti-Peptic Ulcer Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Anti-Peptic Ulcer Drugs by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Anti-Peptic Ulcer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue and Revenue Share by Application (2013-2018)
10 Global Anti-Peptic Ulcer Drugs Market Segment by Type
10.1 Global Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Peptic Ulcer Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Peptic Ulcer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Proton Pump Inhibitors (PPIs) Sales Growth and Price
10.2.1 Global Proton Pump Inhibitors (PPIs) Sales Growth (2013-2018)
10.2.2 Global Proton Pump Inhibitors (PPIs) Price (2013-2018)
10.3 Potassium-Competitive Acid Blockers (P-CAB) Sales Growth and Price
10.3.1 Global Potassium-Competitive Acid Blockers (P-CAB) Sales Growth (2013-2018)
10.3.2 Global Potassium-Competitive Acid Blockers (P-CAB) Price (2013-2018)
10.4 Antacids Sales Growth and Price
10.4.1 Global Antacids Sales Growth (2013-2018)
10.4.2 Global Antacids Price (2013-2018)
10.5 H2 Antagonists Sales Growth and Price
10.5.1 Global H2 Antagonists Sales Growth (2013-2018)
10.5.2 Global H2 Antagonists Price (2013-2018)
10.6 Ulcer Protective Drugs Sales Growth and Price
10.6.1 Global Ulcer Protective Drugs Sales Growth (2013-2018)
10.6.2 Global Ulcer Protective Drugs Price (2013-2018)
11 Global Anti-Peptic Ulcer Drugs Market Segment by Application
11.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Application (2013-2018)
11.2 Gastritis Sales Growth (2013-2018)
11.3 Gastric Ulcers Sales Growth (2013-2018)
11.4 Duodenal Ulcers Sales Growth (2013-2018)
11.5 Gastroesophageal Reflux Disease (GERD) Sales Growth (2013-2018)
12 Anti-Peptic Ulcer Drugs Market Forecast (2018-2023)
12.1 Global Anti-Peptic Ulcer Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Peptic Ulcer Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Peptic Ulcer Drugs Market Forecast (2018-2023)
12.2.2 Europe Anti-Peptic Ulcer Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Forecast (2018-2023)
12.2.4 South America Anti-Peptic Ulcer Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Peptic Ulcer Drugs Market Forecast (2018-2023)
12.3 Anti-Peptic Ulcer Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Peptic Ulcer Drugs Market Share Forecast by Type (2018-2023)
12.4 Anti-Peptic Ulcer Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Peptic Ulcer Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Anti-Peptic Ulcer Drugs Picture
Table Product Specifications of Anti-Peptic Ulcer Drugs
Figure Global Anti-Peptic Ulcer Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Anti-Peptic Ulcer Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Anti-Peptic Ulcer Drugs by Types in 2017
Figure Proton Pump Inhibitors (PPIs) Picture
Table Major Manufacturers of Proton Pump Inhibitors (PPIs)
Figure Potassium-Competitive Acid Blockers (P-CAB) Picture
Table Major Manufacturers of Potassium-Competitive Acid Blockers (P-CAB)
Figure Antacids Picture
Table Major Manufacturers of Antacids
Figure H2 Antagonists Picture
Table Major Manufacturers of H2 Antagonists
Figure Ulcer Protective Drugs Picture
Table Major Manufacturers of Ulcer Protective Drugs
Figure Anti-Peptic Ulcer Drugs Sales Market Share by Applications in 2017
Figure Gastritis Picture
Figure Gastric Ulcers Picture
Figure Duodenal Ulcers Picture
Figure Gastroesophageal Reflux Disease (GERD) Picture
Figure United States Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-Peptic Ulcer Drugs Revenue (Value) and Growth Rate (2013-2023)
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Anti-Peptic Ulcer Drugs Product
Table AstraZeneca Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global AstraZeneca Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Ask-pharm Headquarter, Established, Main Business and Finance Overview (2017)
Table Ask-pharm Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Ask-pharm Anti-Peptic Ulcer Drugs Product
Table Ask-pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ask-pharm Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Ask-pharm Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Takeda Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Takeda Anti-Peptic Ulcer Drugs Product
Table Takeda Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Takeda Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Yangtze River Pharm Headquarter, Established, Main Business and Finance Overview (2017)
Table Yangtze River Pharm Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Yangtze River Pharm Anti-Peptic Ulcer Drugs Product
Table Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Shandong Luoxin Headquarter, Established, Main Business and Finance Overview (2017)
Table Shandong Luoxin Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Shandong Luoxin Anti-Peptic Ulcer Drugs Product
Table Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shandong Luoxin Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Huadong Medicine Headquarter, Established, Main Business and Finance Overview (2017)
Table Huadong Medicine Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Huadong Medicine Anti-Peptic Ulcer Drugs Product
Table Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Huadong Medicine Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Huadong Medicine Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Changzhou Siyao Headquarter, Established, Main Business and Finance Overview (2017)
Table Changzhou Siyao Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Changzhou Siyao Anti-Peptic Ulcer Drugs Product
Table Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Changzhou Siyao Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Beijing Yuekang Headquarter, Established, Main Business and Finance Overview (2017)
Table Beijing Yuekang Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Beijing Yuekang Anti-Peptic Ulcer Drugs Product
Table Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Beijing Yuekang Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Guangdong Dahua Headquarter, Established, Main Business and Finance Overview (2017)
Table Guangdong Dahua Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Guangdong Dahua Anti-Peptic Ulcer Drugs Product
Table Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Guangdong Dahua Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Xian Janssen Headquarter, Established, Main Business and Finance Overview (2017)
Table Xian Janssen Anti-Peptic Ulcer Drugs Production Bases, Sales Regions and Major Competitors
Table Xian Janssen Anti-Peptic Ulcer Drugs Product
Table Xian Janssen Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Xian Janssen Anti-Peptic Ulcer Drugs Sales Market Share in 2017
Figure Global Xian Janssen Anti-Peptic Ulcer Drugs Revenue Market Share in 2017
Table Global Anti-Peptic Ulcer Drugs Sales by Manufacturer (2016-2017)
Figure Global Anti-Peptic Ulcer Drugs Sales Market Share by Manufacturer in 2016
Figure Global Anti-Peptic Ulcer Drugs Sales Market Share by Manufacturer in 2017
Table Global Anti-Peptic Ulcer Drugs Revenue by Manufacturer (2016-2017)
Figure Global Anti-Peptic Ulcer Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Anti-Peptic Ulcer Drugs Revenue Market Share by Manufacturer in 2017
Table Global Anti-Peptic Ulcer Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Anti-Peptic Ulcer Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-Peptic Ulcer Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure Global Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2013-2018)
Table Global Anti-Peptic Ulcer Drugs Sales by Regions (2013-2018)
Table Global Anti-Peptic Ulcer Drugs Sales Market Share by Regions (2013-2018)
Table Global Anti-Peptic Ulcer Drugs Revenue by Regions (2013-2018)
Figure Global Anti-Peptic Ulcer Drugs Revenue Market Share by Regions in 2013
Figure Global Anti-Peptic Ulcer Drugs Revenue Market Share by Regions in 2017
Figure North America Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure North America Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure Europe Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2013-2018)
Figure South America Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure South America Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2013-2018)
Figure North America Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Sales by Countries (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Sales Market Share by Countries (2013-2018)
Figure North America Anti-Peptic Ulcer Drugs Sales Market Share by Countries in 2013
Figure North America Anti-Peptic Ulcer Drugs Sales Market Share by Countries in 2017
Table North America Anti-Peptic Ulcer Drugs Revenue by Countries (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Anti-Peptic Ulcer Drugs Revenue Market Share by Countries in 2013
Figure North America Anti-Peptic Ulcer Drugs Revenue Market Share by Countries in 2017
Figure United States Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure Canada Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Sales by Manufacturer (2016-2017)
Figure North America Anti-Peptic Ulcer Drugs Sales Market Share by Manufacturer in 2016
Figure North America Anti-Peptic Ulcer Drugs Sales Market Share by Manufacturer in 2017
Table North America Anti-Peptic Ulcer Drugs Revenue by Manufacturer (2016-2017)
Figure North America Anti-Peptic Ulcer Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Anti-Peptic Ulcer Drugs Revenue Market Share by Manufacturer in 2017
Table North America Anti-Peptic Ulcer Drugs Sales by Type (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Sales Share by Type (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Revenue by Type (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Revenue Share by Type (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Sales by Application (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Sales Share by Application (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Revenue by Application (2013-2018)
Table North America Anti-Peptic Ulcer Drugs Revenue Share by Application (2013-2018)
Figure Europe Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2013-2018)
Table Europe Anti-Peptic Ulcer Drugs Sales by Countries (2013-2018)
Table Europe Anti-Peptic Ulcer Drugs Sales Market Share by Countries (2013-2018)
Table Europe Anti-Peptic Ulcer Drugs Revenue by Countries (2013-2018)
Figure Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Countries in 2016
Figure Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Countries in 2017
Figure Germany Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure UK Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure France Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure Russia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Figure Italy Anti-Peptic Ulcer Drugs Sales and Growth Rate (2013-2018)
Table Europe Anti-Peptic Ulcer Drugs Sales by Manufacturer (2016-2017)
Figure Europe Anti-Peptic Ulcer Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Anti-Peptic Ulcer Drugs Sales Market Share by
  • Global Exocrine Pancreatic Insufficiency Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 10-Oct-2018        Price: US 3480 Onwards        Pages: 130
    Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. Scope of the Report: This report studies the Exocrine Pancreatic Insufficiency market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Exocrine Pancreatic Insufficiency market......
  • Global Irritable Bowel Syndrome (IBS) Market Insights, Forecast to 2025
    Published: 08-Oct-2018        Price: US 3900 Onwards        Pages: 112
    This report studies the global market size of Irritable Bowel Syndrome (IBS) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irritable Bowel Syndrome (IBS) in these regions. This research report categorizes the global Irritable Bowel Syndrome (IBS) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, gro......
  • Global Inflammatory Bowel Disease Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Inflammatory Bowel Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnerin......
  • Global Gastrointestinal Symptoms Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the gastrointestinal symptom partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Gastrointestinal Symptoms Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering d......
  • Global Irritable Bowel Syndrome Partnering 2012-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the irritable bowel syndrome partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Irritable Bowel Syndrome Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering de......
  • Global Esophageal Reflux Partnering 2012-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the esophageal reflux partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Esophageal Reflux Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - T......
  • Global Peptic Ulcer Partnering 2012-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the peptic ulcer partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Peptic Ulcer Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals b......
  • Global Ulcerative Colitis Partnering 2012-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the ulcerative colitis partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Ulcerative Colitis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals -......
  • Global Gastrointestinal Partnering 2012-2018: Deal trends, players and financials
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 700
    "Delivery of this report will take 1-3 days after purchase." The Global Gastrointestinal Partnering 2012-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the gastrointestinal partnering deals and agreements entered into by the worlds leading healthcare companies Global Gastrointestinal Partnering 2012 to 2018 provides the full collection of Gastrointestinal disease deals signed between the world's pha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs